Debbie Lin - Bench International

07 Mar AI enabled medical devices where are we innovating

Posted at 20:07h in Board Insights

Insight by: Debbie Lin Calling all biohackers. Your apple watch will soon be able to non-invasively track glucose continuously. Dubbed E5, Apple hit a major milestone recently in their moonshot project to develop a non-invasive glucose monitor. Current wearable glucose monitors detect glucose levels through the...

04 Jan Generative AI in Healthcare

Posted at 22:13h in Board Insights

Insight by: Debbie Lin As we round out 2022 and look back at the many incredible scientific breakthroughs of the year, witness, these 2022 advancements, to name only a few: 1. A giant Icelandic fan sucking 4000 metic tons of carbon dioxide out of the sky 2. We...

07 Dec Translating our Genomes into (hella) bytes of data

Posted at 19:17h in Board Insights

Insight by: Debbie Lin As genomic sequencing becomes prevalent in our lives. Each individual’s genetic response to disease and our environment, will be uploaded to The Cloud not just once but perhaps in multiple copy iterations as snapshot copies of our genome are analyzed to understand...

31 Oct Data Acquisition-Should companies Go Wide or Go Deep?

Posted at 19:07h in Board Insights

Insight by: Debbie Lin We are in an era of “Show me the Data.” Healthcare companies are in a data acquisition land grab. Making the data meaningful and actionable is bigger challenge. It is where the real value lies. In his recent post, David Whelan discussed...

03 Oct Cancer Moonshot

Posted at 20:46h in Board Insights

Insight by: Debbie Lin In a recent speech this September to leaders in science and medicine commemorating President John F. Kennedy’s space race to the Moon, President Biden spoke about his goal to win the race against cancer by highlighting a federal program, a part of...

31 Aug Big tech helps scale healthcare access

Posted at 17:24h in Board Insights

Insight by: Debbie Lin The US, historically, has been characterized by vast inequities in health outcomes across socio-economic groups. Poor outcomes across diseases from tuberculosis to cardiovascular disease were found to be associated with basic social infrastructure problems such as poor housing, malnutrition and poor education...

28 Jul Pharma Leaders are challenged to show demonstrable outcomes for investments in Digital Health

Posted at 19:27h in Board Insights

Insight by: Debbie Lin The big challenge: Leaders in Pharma and Biotech are being challenged to tie digital health partnerships and investments to measurable outcomes and key metrics that can demonstrate success to the business and forecast a return on investment. Demonstrating outcomes that drive the...

06 Jul The Reimagined Healthcare Consumer Can Democratize Healthcare

Posted at 12:09h in Board Insights

Insight by: Debbie Lin The pandemic has shifted the motivations and expectations of consumers more rapidly than ever before. Consumers today are reimagining how they choose products. Today, the reimagined consumer makes purchasing decisions based on factors beyond price and quality. Importantly, features such as ease...

16 Jun History of Companion Diagnostics

Posted at 12:43h in Board Insights

Insight by: Debbie Lin For any life science company or startup company co-developing a drug with a medical device/digital health technology can be extremely challenging. One just has to look to the history of companion diagnostics to view the road that lies ahead. Valla et al.’s paper...

Author: Debbie Lin